Stage I Ovarian Germ Cell Tumors
Stage II Ovarian Germ Cell Tumors
Stage III Ovarian Germ Cell Tumors
Stage IV Ovarian Germ Cell Tumors

Stage I Ovarian Germ Cell Tumors

Treatment depends on whether the tumor is dysgerminoma or another type of germ cell tumor.

Treatment of dysgerminoma may include the following:

• Unilateral salpingo-oophorectomy with or without lymphangiography (an x-ray study of the lymph system, the tissues and organs that filter and destroy harmful substances and help fight infection and disease) or CT scan (a series of detailed pictures of areas inside the body, created by a computer linked to an x-ray machine).
• Unilateral salpingo-oophorectomy followed by observation (closely monitoring a patient’s condition without giving any treatment until symptoms appear or change).
• Unilateral salpingo-oophorectomy followed by radiation therapy.
• Unilateral salpingo-oophorectomy followed by chemotherapy.

Treatment of other germ cell tumors may be either:

• unilateral salpingo-oophorectomy followed by careful observation; or
• unilateral salpingo-oophorectomy, sometimes followed by combination chemotherapy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I ovarian germ cell tumor.

Treatment depends on whether the tumor is dysgerminoma or another type of germ cell tumor.

Treatment of dysgerminoma may be either:

• total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by radiation therapy or combination chemotherapy; or
• unilateral salpingo-oophorectomy followed by chemotherapy.

Treatment of other germ cell tumors may include the following:

• Unilateral salpingo-oophorectomy followed by combination chemotherapy.
• Second-look surgery (surgery performed after primary treatment to determine whether tumor cells remain).
• A clinical trial of new treatment options.

Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage II ovarian germ cell tumor.

Treatment depends on whether the tumor is dysgerminoma or another type of germ cell tumor.

Treatment of dysgerminoma may include the following:

• Total abdominal hysterectomy and bilateral salpingo-oophorectomy, with removal of as much of the cancer in the pelvis and abdomen as possible.
• Unilateral salpingo-oophorectomy followed by chemotherapy.

Treatment of other germ cell tumors may include the following:

• Total abdominal hysterectomy and bilateral salpingo-oophorectomy, with removal of as much of the cancer in the pelvis and abdomen as possible. Chemotherapy will be given before and/or after surgery.
• Unilateral salpingo-oophorectomy followed by chemotherapy.
• Second-look surgery (surgery performed after primary treatment to determine whether tumor cells remain).
• A clinical trial of new treatment options.

Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III ovarian germ cell tumor.

Treatment depends on whether the tumor is dysgerminoma or another type of germ cell tumor.

Treatment of dysgerminoma may include the following:

• Total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by chemotherapy, with removal of as much of the cancer in the pelvis and abdomen as possible.
• Unilateral salpingo-oophorectomy followed by chemotherapy.

Treatment of other germ cell tumors may include the following:

• Total abdominal hysterectomy and bilateral salpingo-oophorectomy, with removal of as much of the cancer in the pelvis and abdomen as possible. Chemotherapy will be given before and/or after surgery.
• Unilateral salpingo-oophorectomy followed by chemotherapy.
• Second-look surgery (surgery performed after primary treatment to determine whether tumor cells remain).
• A clinical trial of new treatment options.

Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage IV ovarian germ cell tumor.

Back to Top

< Previous Section  |  Next Section >